Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Aesthetic Plastic Surgery|March 23, 2018
Evaluation of Safe Systemic Immunosuppression Created with Dexamethasone in Prevention of Capsular Contracture: A Glance to Distinct Perspectives with Toll-Like ReceptorsOzlem Colak, Kadri Ozer, Adile Dikmen, et al.Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|November 13, 2023
Primary epithelioid angiosarcoma of endometriumSelim Sevim, Ekin Gedik, Hilal Ozakinci, et al.Journal of Plastic Surgery and Hand Surgery|February 1, 2023
Comparıson of the effect of the autogenıc and xenogenıc use of platelet-rıch plasma on rabbıt chondrocutaneous composıte graft survıvalHande Akdeniz, Koray Gursoy, Gokay Baykara, et al.Updates in Surgery|November 3, 2024
Combination of grade and spread through air spaces (STAS) predicts recurrence in early stage lung adenocarcinoma: a retrospective cohort studyBetul Bahar Isgir, Gokhan Kocaman, Yusuf Kahya, et al.Journal of Pathology and Translational Medicine|March 9, 2026
Can micro-CT distinguish between solid lung tumors? A comparative evaluation including solid adenocarcinoma, non-keratinizing squamous cell carcinoma, and carcinoid tumorSelim Sevim, Serpil Dizbay Sak, Kaan Orhan, et al.Diagnostics (Basel, Switzerland)|February 25, 2022
A CT-Based Radiomic Signature for the Differentiation of Pulmonary Hamartomas from Carcinoid TumorsAyten Kayi Cangir, Kaan Orhan, Yusuf Kahya, et al.JTO Clinical and Research Reports|October 10, 2024
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression PanelHilal Ozakinci, Aileen Y Alontaga, Pedro Cano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung CancerRyoji Kato, Hitendra S Solanki, Hilal Ozakinci, et al.Molecular Cancer Therapeutics|January 26, 2026
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to LurbinectedinMisty D Shields, Katherine G Minton, Hilal Ozakinci, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in KRAS G12C -Mutant NSCLCHilal Ozakinci, Bina Desai, Denise Kalos, et al.Pageof 2